UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006044
Receipt number R000006701
Scientific Title The Impact of use of Energy Devices during Parenchymal Transection of the Liver: a multicenter randomized controlled trial
Date of disclosure of the study information 2011/07/26
Last modified on 2015/05/11 08:42:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Impact of use of Energy Devices during Parenchymal Transection of the Liver: a multicenter randomized controlled trial

Acronym

EPL trial

Scientific Title

The Impact of use of Energy Devices during Parenchymal Transection of the Liver: a multicenter randomized controlled trial

Scientific Title:Acronym

EPL trial

Region

Japan


Condition

Condition

Liver tumor

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We evaluate the blood loss during parenchymal transection of the liver in making use of energy devices compared with the standard ligation method.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Proportion of cases to the blood loss over 1000ml between the 2 groups

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

use of the energy device

Interventions/Control_2

no use of the energy device

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Patients will undergo hepatectomy without biliary reconstruction. Disease: Hepatocellular carcinoma, intrahepatic cholangiocellular carcinoma, metastatic liver cancer, benign liver tumor
2)PS:0-2
3)adequate bone marrow, liver function and renal function
4)Patients agreed with this study.

Key exclusion criteria

1)the size of tumor is less than 20mm in diameter and tumor is solitary, and located in the surface of the liver.
2)Patinets will undergo hepatectomy and other surgical procedures (excluded cholecystectomy)
3)Patients cannot understand this study.
4)Pregnancy patients
5)Doctors considered that patient was not eligible.

Target sample size

210


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naoto Gotohda

Organization

National Cancer Center Hospital East

Division name

Hepatobiliary pancreatic surgery

Zip code


Address

6-5-1 Kashiwanoha, Kashiwa city, Chiba

TEL

04-7133-1111

Email

ngotohda@east.ncc.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naoto Gotohda

Organization

National Cancer Center Hospital East

Division name

Hepatobiliary pancreatic surgery

Zip code


Address

6-5-1 Kashiwanoha, Kashiwa city, Chiba

TEL

04-7133-1111

Homepage URL


Email

ngotohda@east.ncc.go.jp


Sponsor or person

Institute

National Cancer Center Hospital East

Institute

Department

Personal name



Funding Source

Organization

National Cancer Center

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)

A Grant-in-Aid for cancer research from the Ministry of Health, Welfare and Labor of Japan (21-7-5)


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 07 Month 26 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 04 Month 11 Day

Date of IRB


Anticipated trial start date

2011 Year 05 Month 01 Day

Last follow-up date


Date of closure to data entry

2012 Year 12 Month 04 Day

Date trial data considered complete

2013 Year 01 Month 04 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 07 Month 26 Day

Last modified on

2015 Year 05 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006701


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name